Visão geral da leucemia

1. Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022 Mar 1;8(3):420-44.Texto completo  Resumo

2. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. National Institute of Health. U.S Department of Health and Human Services. ​Cancer stat facts: Leukemia. [internet publication].Texto completo

3. Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a034819.Texto completo  Resumo

4. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer stat facts: leukemia - acute lymphocytic leukemia (ALL). [internet publication].Texto completo

5. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33.Texto completo  Resumo

6. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022 Jul;36(7):1720-48.Texto completo  Resumo

7. Yao Y, Lin X, Li F, et al. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019. Biomed Eng Online. 2022 Jan 11;21(1):4.Texto completo  Resumo

8. Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019 Nov;94(11):1266-87.Texto completo  Resumo

9. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. ​Cancer stat facts: leukemia - chronic lymphocytic leukemia (CLL). 2023 [internet publication].Texto completo

10. Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 Jun 21;131(25):2745-60.Texto completo  Resumo

11. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer stat facts: leukemia - acute myeloid leukemia (AML). [internet publication].Texto completo

12. Sawyers C. Chronic myeloid leukemia. N Engl J Med. 1999 Apr 29;340(17):1330-40. Resumo

13. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: leukemia - chronic myeloid leukemia (CML). [internet publication].Texto completo

14. Tsushima H, Iwanaga M, Miyazaki Y. Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes. Int J Hematol. 2012 Mar;95(3):232-8.Texto completo  Resumo

15. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol. 2018 Mar;93(3):442-59.Texto completo  Resumo

16. Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol. 1997;96:111-6. Resumo

17. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May 19;127(20):2391-405.Texto completo  Resumo

18. Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006 Mar 15;106(6):1306-15.Texto completo  Resumo

19. Sasaki K, Jabbour E, Cortes J, et al. Chronic myeloid leukemia. In: Kantarjian HM, Wolff RA, Rieber AG, eds. The MD Anderson Manual of Medical Oncology. 4th ed. McGraw Hill Education; 2022.

20. Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med. 1996 May;100(5):555-70. Resumo

21. Parry-Jones N, Joshi A, Forconi F, et al. Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V). Br J Haematol. 2020 Dec;191(5):730-7.Texto completo  Resumo

22. Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016 Nov 12;66(6):443-59.Texto completo  Resumo

23. Monnereau A, Slager SL, Hughes AM, et al. Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the interlymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014 Aug;2014(48):115-24.Texto completo  Resumo

24. Paillassa J, Cornet E, Noel S, et al. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up. Blood Cancer J. 2020 May 27;10(5):62.Texto completo  Resumo

25. Hoffman MA. Clinical presentations and complications of hairy cell leukemia. Hematol Oncol Clin North Am. 2006;20:1065-1073. Resumo

26. Flandrin G, Sigaux F, Sebahoun G, et al. Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin Oncol. 1984 Dec;11(4 suppl 2):458-71.